ckd and semaglutide Safety Efficacy of in Patients With Chronic Kidney Disease, With or Without Type 2 Diabetes: A Systematic Review and MetaโAnalysis - Abdullah - 2025 - Endocrinology, Diabetes & Metabolism ๐ The FDA has approved
Description
The MHRAs decision to classify hair loss as common for Mounjaro is notable
Semaglutide targets GLP-1R only
One of the most powerful GLP-1 therapy psychological effects is the reported reduction in the compulsion to eat emotionally
Some research suggests tirzepatide may also influence energy balance and metabolic health, especially when combined with healthy lifestyle habits
Patients must be prepared for the reality that they would need to take some kind of medication for the rest of their life if they intend to keep the weight off
Some people hear that term and worry
